METX — ME Therapeutics Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- CA$32.75m
- CA$31.09m
2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 0.05 | 0.073 | 0.077 | 0.647 |
Net Total Receivables | 0.02 | 0.002 | 0.023 | 0.007 |
Prepaid Expenses | ||||
Total Current Assets | 0.07 | 0.075 | 0.102 | 0.672 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0 | 0 | 0 | 0 |
Net Intangible Assets | ||||
Total Assets | 0.07 | 0.075 | 0.102 | 0.672 |
Payable / Accrued | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.006 | 0.033 | 0.174 | 0.148 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Liabilities | 0.046 | 0.093 | 0.234 | 0.148 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 0.024 | -0.018 | -0.131 | 0.523 |
Total Liabilities & Shareholders' Equity | 0.07 | 0.075 | 0.102 | 0.672 |
Total Common Shares Outstanding |